{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T18:48:03Z","timestamp":1780080483802,"version":"3.54.0"},"reference-count":210,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T00:00:00Z","timestamp":1536624000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000304","name":"Parkinson's UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000304","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2018.00767","type":"journal-article","created":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T00:58:35Z","timestamp":1536627515000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":22,"title":["Neuroimaging of Sleep Disturbances in Movement Disorders"],"prefix":"10.3389","volume":"9","author":[{"given":"Tayyabah","family":"Yousaf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gennaro","family":"Pagano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marios","family":"Politis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,9,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S1353-8020(01)00015-3","article-title":"Non-recognition of depression and other non-motor symptoms in Parkinson's disease","volume":"8","author":"Shulman","year":"2002","journal-title":"Parkinsonism Relat Disord"},{"key":"B2","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/j.1468-1331.2004.00971.x","article-title":"Sleep and sleepiness in patients with Parkinson's disease before and after dopaminergic treatment","volume":"12","author":"Kaynak","year":"2005","journal-title":"Eur J Neurol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1093\/brain\/awm090","article-title":"Hypocretin (orexin) loss in Parkinson's disease","volume":"130","author":"Fronczek","year":"2007","journal-title":"Brain"},{"key":"B4","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/nrneurol.2014.206","article-title":"\u2018The clocks that time us\u2019\u2013circadian rhythms in neurodegenerative disorders","volume":"10","author":"Videnovic","year":"2014","journal-title":"Nat Rev Neurol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.nicl.2018.03.001","article-title":"Serotonergic dysregulation is linked to sleep problems in Parkinson's disease","volume":"18","author":"Wilson","year":"2018","journal-title":"Neuroimage Clin"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1007\/s00415-012-6428-3","article-title":"Positron emission tomography imaging in neurological disorders","volume":"259","author":"Politis","year":"2012","journal-title":"J Neurol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1212\/WNL.0000000000002461","article-title":"Age at onset and Parkinson disease phenotype","volume":"86","author":"Pagano","year":"2016","journal-title":"Neurology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1007\/s00702-017-1823-7","article-title":"The serotonergic system in Parkinson's patients with dyskinesia: evidence from imaging studies","volume":"125","author":"Pagano","year":"2017","journal-title":"J Neural Transm."},{"key":"B9","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s11910-017-0794-2","article-title":"PET molecular imaging research of levodopa-induced dyskinesias in Parkinson's disease","volume":"17","author":"Pagano","year":"2017","journal-title":"Curr Neurol Neurosci Rep"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e1654","DOI":"10.1212\/WNL.0000000000005475","article-title":"Diabetes mellitus and Parkinson disease","volume":"90","author":"Pagano","year":"2018","journal-title":"Neurology"},{"key":"B11","article-title":"In: Colten HR, Altevogt BM, editors. Sleep disorders and sleep deprivation: An unmet public health problem","volume-title":"Sleep Disorders and Sleep Deprivation: An Unmet Public Health Problem.","author":"Colten","year":"2006"},{"key":"B12","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/nrn895","article-title":"The neurobiology of sleep: genetics, cellular physiology and subcortical networks","volume":"3","author":"Pace-Schott","year":"2002","journal-title":"Nat Rev Neurosci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.neuron.2010.11.032","article-title":"Sleep state switching","volume":"68","author":"Saper","year":"2010","journal-title":"Neuron"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1152\/physrev.00032.2011","article-title":"Control of sleep and wakefulness","volume":"92","author":"Brown","year":"2012","journal-title":"Physiol Rev"},{"key":"B15","doi-asserted-by":"publisher","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","article-title":"Parkinson disease","volume":"3","author":"Poewe","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"B16","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/S1474-4422(16)00057-0","article-title":"Idiopathic rapid eye movement sleep behaviour disorder: diagnosis, management, and the need for neuroprotective interventions","volume":"15","author":"Iranzo","year":"2016","journal-title":"Lancet Neurol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/S1474-4422(06)70476-8","article-title":"Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study","volume":"5","author":"Iranzo","year":"2006","journal-title":"Lancet Neurol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/j.1749-6632.2009.05115.x","article-title":"REM sleep behavior disorder: updated review of the core features, the REM sleep behavior disorder-neurodegenerative disease association, evolving concepts, controversies, and future directions","volume":"1184","author":"Boeve","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"B19","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00115-013-3891-8","article-title":"REM sleep behavior disorder as a prodromal stage of alpha-synucleinopathies: symptoms, epidemiology, pathophysiology, diagnosis and therapy","volume":"85","author":"Oertel","year":"2014","journal-title":"Nervenarzt"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1212\/01.wnl.0000340980.19702.6e","article-title":"Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder","volume":"72","author":"Postuma","year":"2009","journal-title":"Neurology"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e89741","DOI":"10.1371\/journal.pone.0089741","article-title":"Neurodegenerative disorder risk in idiopathic REM sleep behavior disorder: study in 174 patients","volume":"9","author":"Iranzo","year":"2014","journal-title":"PLoS ONE"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000006134","article-title":"REM behaviour disorder predicts motor progression and cognitive decline in Parkinson's disease","author":"Pagano","year":"2018","journal-title":"Neurology"},{"key":"B23","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1002\/mds.870050404","article-title":"Sleep disorders and sleep effect in Parkinson's disease","volume":"5","author":"Factor","year":"1990","journal-title":"Mov Disord"},{"key":"B24","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1136\/jnnp-2013-306104","article-title":"REM sleep behaviour disorder is associated with worse quality of life and other non-motor features in early Parkinson's disease","volume":"85","author":"Rolinski","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B25","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1136\/jnnp.69.5.584","article-title":"Health related quality of life in Parkinson's disease: a prospective longitudinal study","volume":"69","author":"Karlsen","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B26","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1159\/000314478","article-title":"Clinical criteria for the diagnosis of Parkinson's disease","volume":"7","author":"Reichmann","year":"2010","journal-title":"Neurodegener Dis"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1002\/mds.22242","article-title":"The prodromal phase of sporadic Parkinson's disease: does it exist and if so how long is it?","volume":"23","author":"Hawkes","year":"2008","journal-title":"Mov Disord"},{"key":"B28","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/mds.24051","article-title":"Toward a redefinition of Parkinson's disease","volume":"27","author":"Stern","year":"2012","journal-title":"Mov Disord"},{"key":"B29","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/nrneurol.2016.152","article-title":"Advances in markers of prodromal Parkinson disease","volume":"12","author":"Postuma","year":"2016","journal-title":"Nat Rev Neurol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/S1474-4422(13)70056-5","article-title":"Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study","volume":"12","author":"Iranzo","year":"2013","journal-title":"Lancet Neurol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.sleep.2012.10.009","article-title":"Delayed emergence of a Parkinsonian disorder or dementia in 81% of older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder: a 16-year update on a previously reported series","volume":"14","author":"Schenck","year":"2013","journal-title":"Sleep Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1001\/jamaneurol.2014.4563","article-title":"Rapid eye movement sleep behavior disorder and neurodegenerative disease","volume":"72","author":"Howell","year":"2015","journal-title":"JAMA Neurol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1212\/WNL.55.9.1410","article-title":"Decreased striatal dopaminergic innervation in REM sleep behavior disorder","volume":"55","author":"Albin","year":"2000","journal-title":"Neurology"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1093\/brain\/123.6.1155","article-title":"Reduced striatal dopamine transporters in idiopathic rapid eye movement sleep behaviour disorder. Comparison with Parkinson's disease and controls","volume":"123","author":"Eisensehr","year":"2000","journal-title":"Brain"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/S1474-4422(10)70216-7","article-title":"Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study [corrected]","volume":"9","author":"Iranzo","year":"2010","journal-title":"Lancet Neurol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1111\/j.1468-1331.2009.02854.x","article-title":"The implication of nigrostriatal dopaminergic degeneration in the pathogenesis of REM sleep behavior disorder","volume":"17","author":"Kim","year":"2010","journal-title":"Eur J Neurol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.smrv.2016.06.006","article-title":"Brain imaging findings in idiopathic REM sleep behavior disorder (RBD)\u2013a systematic review on potential biomarkers for neurodegeneration","volume":"34","author":"Heller","year":"2017","journal-title":"Sleep Med Rev"},{"key":"B38","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/S1474-4422(11)70152-1","article-title":"Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study","volume":"10","author":"Iranzo","year":"2011","journal-title":"Lancet Neurol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1093\/sleep\/26.5.507","article-title":"Increased muscle activity during rapid eye movement sleep correlates with decrease of striatal presynaptic dopamine transporters. IPT and IBZM SPECT imaging in subclinical and clinically manifest idiopathic REM sleep behavior disorder, Parkinson's disease, and controls","volume":"26","author":"Eisensehr","year":"2003","journal-title":"Sleep"},{"key":"B40","doi-asserted-by":"publisher","first-page":"3300","DOI":"10.1016\/j.neurobiolaging.2015.08.025","article-title":"Nigro-caudate dopaminergic deafferentation: a marker of REM sleep behavior disorder?","volume":"36","author":"Arnaldi","year":"2015","journal-title":"Neurobiol Aging"},{"key":"B41","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1002\/mds.1139","article-title":"Rate of progression in Parkinson's disease: a 6-[18F]fluoro-L-dopa PET study","volume":"16","author":"Nurmi","year":"2001","journal-title":"Mov Disord"},{"key":"B42","doi-asserted-by":"publisher","first-page":"895","DOI":"10.5664\/jcsm.5896","article-title":"Increased motor activity during REM sleep is linked with dopamine function in idiopathic REM sleep behavior disorder and Parkinson disease","volume":"12","author":"Zoetmulder","year":"2016","journal-title":"J Clin Sleep Med"},{"key":"B43","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.sleep.2011.10.001","article-title":"Increased perfusion in supplementary motor area during a REM sleep behaviour episode","volume":"12","author":"Dauvilliers","year":"2011","journal-title":"Sleep Med"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1093\/brain\/awv042","article-title":"Ictal SPECT in patients with rapid eye movement sleep behaviour disorder","volume":"138","author":"Mayer","year":"2015","journal-title":"Brain"},{"key":"B45","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1093\/brain\/awl363","article-title":"Restoration of normal motor control in Parkinson's disease during REM sleep","volume":"130","author":"De Cock","year":"2007","journal-title":"Brain"},{"key":"B46","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1212\/WNL.0000000000000130","article-title":"Abnormal metabolic network activity in REM sleep behavior disorder","volume":"82","author":"Holtbernd","year":"2014","journal-title":"Neurology"},{"key":"B47","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1093\/sleep\/20.9.757","article-title":"Contributions of the pedunculopontine region to normal and altered REM sleep","volume":"20","author":"Rye","year":"1997","journal-title":"Sleep"},{"key":"B48","first-page":"1584","article-title":"Neuronal activity in the internal (GPi) and external (GPe) segments of the globus pallidus (GP) of Parkinsonian patients is similar to that in the MPTP-treated primate model of Parkinsonism [abstract]","volume":"19","author":"Vitek","year":"1993","journal-title":"Soc Neurosci Abstr"},{"key":"B49","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.neuroscience.2008.03.085","article-title":"Neurotoxic lesions at the ventral mesopontine junction change sleep time and muscle activity during sleep: an animal model of motor disorders in sleep","volume":"154","author":"Lai","year":"2008","journal-title":"Neuroscience"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/0306-4522(83)90104-5","article-title":"The subcortical afferents to caudate nucleus and putamen in primate: a fluorescence retrograde double labeling study","volume":"10","author":"Parent","year":"1983","journal-title":"Neuroscience"},{"key":"B51","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.sleep.2012.09.018","article-title":"Treatment outcomes in REM sleep behavior disorder","volume":"14","author":"Mccarter","year":"2013","journal-title":"Sleep Med"},{"key":"B52","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1002\/ana.22691","article-title":"Symptoms of rapid eye movement sleep behavior disorder are associated with cholinergic denervation in Parkinson disease","volume":"71","author":"Kotagal","year":"2012","journal-title":"Ann Neurol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.5665\/sleep.5000","article-title":"The role of the serotonergic system in REM sleep behavior disorder","volume":"38","author":"Arnaldi","year":"2015","journal-title":"Sleep"},{"key":"B54","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.1093\/brain\/awv215","article-title":"Clinical correlates of raphe serotonergic dysfunction in early Parkinson's disease","volume":"138","author":"Qamhawi","year":"2015","journal-title":"Brain"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.5665\/sleep.3222","article-title":"Altered nigrostriatal and nigrocortical functional connectivity in rapid eye movement sleep behavior disorder","volume":"36","author":"Ellmore","year":"2013","journal-title":"Sleep"},{"key":"B56","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1093\/brain\/aww124","article-title":"Basal ganglia dysfunction in idiopathic REM sleep behaviour disorder parallels that in early Parkinson's disease","volume":"139","author":"Rolinski","year":"2016","journal-title":"Brain"},{"key":"B57","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1002\/mds.25367","article-title":"Rapid eye movement sleep behavior disorder in Parkinson's disease: magnetic resonance imaging study","volume":"28","author":"Ford","year":"2013","journal-title":"Mov Disord"},{"key":"B58","doi-asserted-by":"publisher","first-page":"26782","DOI":"10.1038\/srep26782","article-title":"Structural brain alterations associated with rapid eye movement sleep behavior disorder in Parkinson's disease","volume":"6","author":"Boucetta","year":"2016","journal-title":"Sci Rep"},{"key":"B59","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.parkreldis.2011.08.023","article-title":"Voxel-based magnetic resonance imaging study of structural brain changes in patients with idiopathic REM sleep behavior disorder","volume":"18","author":"Hanyu","year":"2012","journal-title":"Parkinsonism Relat Disord"},{"key":"B60","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1093\/sleep\/33.6.767","article-title":"Diffusion tensor imaging in idiopathic REM sleep behavior disorder reveals microstructural changes in the brainstem, substantia nigra, olfactory region, and other brain regions","volume":"33","author":"Unger","year":"2010","journal-title":"Sleep"},{"key":"B61","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1002\/ana.22245","article-title":"White and gray matter abnormalities in idiopathic rapid eye movement sleep behavior disorder: a diffusion-tensor imaging and voxel-based morphometry study","volume":"69","author":"Scherfler","year":"2011","journal-title":"Ann Neurol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1002\/mds.25820","article-title":"Patterns of cortical thinning in idiopathic rapid eye movement sleep behavior disorder","volume":"30","author":"Rahayel","year":"2015","journal-title":"Mov Disord"},{"key":"B63","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1093\/brain\/awt152","article-title":"The coeruleus\/subcoeruleus complex in rapid eye movement sleep behaviour disorders in Parkinson's disease","volume":"136","author":"Garcia-Lorenzo","year":"2013","journal-title":"Brain"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.parkreldis.2014.06.012","article-title":"Reduced thalamic volume in Parkinson disease with REM sleep behavior disorder: volumetric study","volume":"20","author":"Salsone","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"key":"B65","doi-asserted-by":"publisher","first-page":"7111","DOI":"10.1523\/JNEUROSCI.0347-11.2011","article-title":"Impaired GABA and glycine transmission triggers cardinal features of rapid eye movement sleep behavior disorder in mice","volume":"31","author":"Brooks","year":"2011","journal-title":"J Neurosci"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1002\/mds.23135","article-title":"Parkinson's disease symptoms: the patient's perspective","volume":"25","author":"Politis","year":"2010","journal-title":"Mov Disord"},{"key":"B67","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/mds.21727","article-title":"Nighttime sleep problems and daytime sleepiness in Parkinson's disease","volume":"23","author":"Verbaan","year":"2008","journal-title":"Mov Disord"},{"key":"B68","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1212\/WNL.64.12_suppl_3.S12","article-title":"Sleep issues in Parkinson's disease","volume":"64","author":"Adler","year":"2005","journal-title":"Neurology"},{"key":"B69","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1001\/jama.287.4.455","article-title":"Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease: a survey by the Canadian Movement Disorders Group","volume":"287","author":"Hobson","year":"2002","journal-title":"JAMA"},{"key":"B70","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.smrv.2005.01.001","article-title":"Excessive daytime sleepiness in Parkinsonism","volume":"9","author":"Arnulf","year":"2005","journal-title":"Sleep Med Rev"},{"key":"B71","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1001\/archneur.59.6.986","article-title":"Contributions of dopaminergic drugs and disease severity to daytime sleepiness in Parkinson disease","volume":"59","author":"O'suilleabhain","year":"2002","journal-title":"Arch Neurol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.sleep.2005.03.011","article-title":"Progressive sleep \u2018destructuring\u2019 in Parkinson's disease. A polysomnographic study in 46 patients","volume":"6","author":"Diederich","year":"2005","journal-title":"Sleep Med"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1093\/brain\/awm097","article-title":"Hypocretin (orexin) cell loss in Parkinson's disease","volume":"130","author":"Thannickal","year":"2007","journal-title":"Brain"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1212\/WNL.57.8.1392","article-title":"Daytime sleepiness and other sleep disorders in Parkinson's disease","volume":"57","author":"Ondo","year":"2001","journal-title":"Neurology"},{"key":"B75","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1212\/WNL.58.3.465","article-title":"Evaluation of somnolence in Parkinson's disease: comparison with age- and sex-matched controls","volume":"58","author":"Tan","year":"2002","journal-title":"Neurology"},{"key":"B76","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/S1389-9457(03)00105-9","article-title":"Excessive daytime sleepiness in Parkinson's disease as assessed by Epworth Sleepiness Scale (ESS)","volume":"4","author":"Kumar","year":"2003","journal-title":"Sleep Med"},{"key":"B77","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s007020170098","article-title":"A study of excessive daytime sleepiness and its clinical significance in three groups of Parkinson's disease patients taking pramipexole, cabergoline and levodopa mono and combination therapy","volume":"108","author":"Pal","year":"2001","journal-title":"J Neural Transm."},{"key":"B78","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1046\/j.1365-2869.2000.00201.x","article-title":"FAST TRACK: daytime sleepiness in Parkinson's disease","volume":"9","author":"Rye","year":"2000","journal-title":"J Sleep Res"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1212\/WNL.58.7.1019","article-title":"Parkinson's disease and sleepiness: an integral part of PD","volume":"58","author":"Arnulf","year":"2002","journal-title":"Neurology"},{"key":"B80","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1002\/mds.10429","article-title":"Sleepiness in Parkinson's disease: a controlled study","volume":"18","author":"Brodsky","year":"2003","journal-title":"Mov Disord"},{"key":"B81","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1136\/jnnp-2014-308764","article-title":"Cholinesterase inhibitors for Parkinson's disease: a systematic review and meta-analysis","volume":"86","author":"Pagano","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B82","doi-asserted-by":"publisher","first-page":"371","DOI":"10.7861\/clinmedicine.16-4-371","article-title":"Imaging in Parkinson's disease","volume":"16","author":"Pagano","year":"2016","journal-title":"Clin Med."},{"key":"B83","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1007\/s00259-016-3349-x","article-title":"Cholinergic imaging in dementia spectrum disorders","volume":"43","author":"Roy","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"B84","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1093\/brain\/awy072","article-title":"Nucleus basalis of Meynert degeneration precedes and predicts cognitive impairment in Parkinson's disease","volume":"141","author":"Schulz","year":"2018","journal-title":"Brain"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1007\/s00259-016-3324-6","article-title":"Current status of PET imaging in Huntington's disease","volume":"43","author":"Pagano","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"B86","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1159\/000276402","article-title":"Excessive daytime sleepiness in Parkinson's disease: characteristics and determinants","volume":"63","author":"Poryazova","year":"2010","journal-title":"Eur Neurol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.parkreldis.2014.11.015","article-title":"Constipation is reduced by beta-blockers and increased by dopaminergic medications in Parkinson's disease","volume":"21","author":"Pagano","year":"2015","journal-title":"Parkinsonism Relat Disord"},{"key":"B88","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1002\/mds.26967","article-title":"Urinary dysfunction in early de novo patients with Parkinson's disease","volume":"32","author":"Pagano","year":"2017","journal-title":"Mov Disord"},{"key":"B89","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/ene.13503","article-title":"Constipation is not associated with dopamine transporter pathology in early drug-naive patients with Parkinson's disease","volume":"25","author":"Pagano","year":"2018","journal-title":"Eur J Neurol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.jns.2018.02.032","article-title":"Excessive daytime sleepiness may be associated with caudate denervation in Parkinson disease","volume":"387","author":"Yousaf","year":"2018","journal-title":"J Neurol Sci"},{"key":"B91","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s00415-006-0483-6","article-title":"Association of daytime sleepiness with nigrostriatal dopaminergic degeneration in early Parkinson's disease","volume":"254","author":"Happe","year":"2007","journal-title":"J Neurol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1093\/sleep\/29.7.917","article-title":"Excessive daytime sleepiness in Parkinson disease: a SPECT study","volume":"29","author":"Matsui","year":"2006","journal-title":"Sleep"},{"key":"B93","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/j.1460-9568.2009.07062.x","article-title":"Basal ganglia control of sleep-wake behavior and cortical activation","volume":"31","author":"Qiu","year":"2010","journal-title":"Eur J Neurosci"},{"key":"B94","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.expneurol.2008.07.021","article-title":"Evidence of dopamine dysfunction in the hypothalamus of patients with Parkinson's disease: an In vivo 11C-raclopride PET study","volume":"214","author":"Politis","year":"2008","journal-title":"Exp Neurol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1212\/WNL.0000000000003396","article-title":"Sleep problems and hypothalamic dopamine D3 receptor availability in Parkinson disease","volume":"87","author":"Pagano","year":"2016","journal-title":"Neurology"},{"key":"B96","doi-asserted-by":"publisher","first-page":"367","DOI":"10.2174\/157015908787386050","article-title":"Neurophysiology of sleep and wakefulness: basic science and clinical implications","volume":"6","author":"Schwartz","year":"2008","journal-title":"Curr Neuropharmacol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1016\/S1353-8020(11)70174-2","article-title":"Sleep regulatory centres dysfunction in Parkinson's disease patients with excessive daytime sleepiness","volume":"18","author":"Pavese","year":"2012","journal-title":".Parkinsonism Relat Disord"},{"key":"B98","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1007\/s00415-011-6187-6","article-title":"Widespread cortical and subcortical brain atrophy in Parkinson's disease with excessive daytime sleepiness","volume":"259","author":"Kato","year":"2012","journal-title":"J Neurol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"422","DOI":"10.3109\/00207454.2015.1023437","article-title":"Multimodal imaging evaluation of excessive daytime sleepiness in Parkinson's disease","volume":"126","author":"Chondrogiorgi","year":"2016","journal-title":"Int J Neurosci"},{"key":"B100","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.parkreldis.2006.01.007","article-title":"Disruptions of the fornix fiber in Parkinsonian patients with excessive daytime sleepiness","volume":"12","author":"Matsui","year":"2006","journal-title":"Parkinsonism Relat Disord"},{"key":"B101","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.parkreldis.2010.01.002","article-title":"Sleep disturbances and brain MRI morphometry in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy\u2013a comparative study","volume":"16","author":"Gama","year":"2010","journal-title":"Parkinsonism Relat Disord"},{"key":"B102","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.5665\/sleep.3108","article-title":"Daytime sleepiness is associated with decreased default mode network connectivity in both young and cognitively intact elderly subjects","volume":"36","author":"Ward","year":"2013","journal-title":"Sleep"},{"key":"B103","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1097\/WNR.0000000000000418","article-title":"Daytime sleepiness is associated with altered resting thalamocortical connectivity","volume":"26","author":"Killgore","year":"2015","journal-title":"Neuroreport"},{"key":"B104","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.parkreldis.2016.01.012","article-title":"Neural substrates of excessive daytime sleepiness in early drug naive Parkinson's disease: a resting state functional MRI study","volume":"24","author":"Wen","year":"2016","journal-title":"Parkinsonism Relat Disord"},{"key":"B105","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.sleep.2005.01.008","article-title":"Repeated IV doses of iron provides effective supplemental treatment of restless legs syndrome","volume":"6","author":"Earley","year":"2005","journal-title":"Sleep Med"},{"key":"B106","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1093\/sleep\/32.6.772","article-title":"Polysomnographic and health-related quality of life correlates of restless legs syndrome in the Sleep Heart Health Study","volume":"32","author":"Winkelman","year":"2009","journal-title":"Sleep"},{"key":"B107","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.sleep.2010.07.007","article-title":"Restless legs syndrome: understanding its consequences and the need for better treatment","volume":"11","author":"Earley","year":"2010","journal-title":"Sleep Med"},{"key":"B108","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/S0149-2918(04)90136-1","article-title":"Evaluating the quality of life of patients with restless legs syndrome","volume":"26","author":"Abetz","year":"2004","journal-title":"Clin Ther"},{"key":"B109","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1001\/archinte.165.11.1286","article-title":"Restless legs syndrome prevalence and impact: REST general population study","volume":"165","author":"Allen","year":"2005","journal-title":"Arch Intern Med"},{"key":"B110","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s11136-006-9142-8","article-title":"Burden of restless legs syndrome on health-related quality of life","volume":"16","author":"Kushida","year":"2007","journal-title":"Qual Life Res"},{"key":"B111","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.sleep.2008.01.002","article-title":"Assessing health-related quality of life in patients with restless legs syndrome","volume":"10","author":"Happe","year":"2009","journal-title":"Sleep Med"},{"key":"B112","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/mds.23430","article-title":"Prevalence and disease burden of primary restless legs syndrome: results of a general population survey in the United States","volume":"26","author":"Allen","year":"2011","journal-title":"Mov Disord"},{"key":"B113","first-page":"S207","article-title":"The real burden of restless legs syndrome: clinical and economic outcomes","volume":"18","author":"Salas","year":"2012","journal-title":"Am J Manag Care"},{"key":"B114","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.5664\/jcsm.3084","article-title":"Restless legs syndrome in an appalachian primary care population: prevalence, demographic and lifestyle correlates, and burden","volume":"9","author":"Innes","year":"2013","journal-title":"J Clin Sleep Med"},{"key":"B115","doi-asserted-by":"publisher","first-page":"e0140632","DOI":"10.1371\/journal.pone.0140632","article-title":"The humanistic and economic burden of restless legs syndrome","volume":"10","author":"Durgin","year":"2015","journal-title":"PLoS ONE"},{"key":"B116","doi-asserted-by":"publisher","first-page":"xv","DOI":"10.1016\/j.jsmc.2015.05.017","article-title":"Restless legs syndrome\/willis-ekbom disease morbidity: burden, quality of life, cardiovascular aspects, and sleep","volume":"10","author":"Stevens","year":"2015","journal-title":"Sleep Med Clin."},{"key":"B117","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1093\/brain\/awm244","article-title":"Where dopamine meets opioids: a meta-analysis of the placebo effect in restless legs syndrome treatment studies","volume":"131","author":"Fulda","year":"2008","journal-title":"Brain"},{"key":"B118","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/mds.26456","article-title":"Progression of nonmotor symptoms in subgroups of patients with non-dopamine-deficient Parkinsonism","volume":"31","author":"Taylor","year":"2016","journal-title":"Mov Disord"},{"key":"B119","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1080\/17425255.2016.1194393","article-title":"Clinical pharmacology and efficacy of rotigotine (Neupro(R) patch) in the treatment of restless leg syndrome","volume":"12","author":"Ferini-Strambi","year":"2016","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"B120","doi-asserted-by":"publisher","first-page":"e14","DOI":"10.1097\/RLU.0000000000000916","article-title":"99mTc-TRODAT-1 SPECT as a potential neuroimaging biomarker in patients with restless legs syndrome","volume":"41","author":"Lin","year":"2016","journal-title":"Clin Nucl Med"},{"key":"B121","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1093\/sleep\/34.3.341","article-title":"The dopamine transporter is decreased in the striatum of subjects with restless legs syndrome","volume":"34","author":"Earley","year":"2011","journal-title":"Sleep"},{"key":"B122","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1212\/WNL.54.2.502","article-title":"An FDOPA PET study in patients with periodic limb movement disorder and restless legs syndrome","volume":"54","author":"Ruottinen","year":"2000","journal-title":"Neurology"},{"key":"B123","doi-asserted-by":"publisher","first-page":"405","DOI":"10.5665\/sleep.5452","article-title":"A four-year longitudinal study on restless legs syndrome in Parkinson disease","volume":"39","author":"Moccia","year":"2016","journal-title":"Sleep"},{"key":"B124","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1093\/brain\/awl163","article-title":"Support for dopaminergic hypoactivity in restless legs syndrome: a PET study on D2-receptor binding","volume":"129","author":"Cervenka","year":"2006","journal-title":"Brain"},{"key":"B125","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1212\/WNL.52.5.932","article-title":"Striatal dopaminergic function in restless legs syndrome: 18F-dopa and 11C-raclopride PET studies","volume":"52","author":"Turjanski","year":"1999","journal-title":"Neurology"},{"key":"B126","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1007\/PL00007859","article-title":"SPECT imaging of striatal pre- and postsynaptic dopaminergic status in restless legs syndrome with periodic leg movements in sleep","volume":"249","author":"Michaud","year":"2002","journal-title":"J Neurol"},{"key":"B127","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1111\/j.1468-1331.2012.03705.x","article-title":"Increased striatal dopamine transporter density in moderately severe old restless legs syndrome patients","volume":"19","author":"Kim","year":"2012","journal-title":"Eur J Neurol"},{"key":"B128","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1097\/00006231-200401000-00008","article-title":"Normal striatal D2 receptor binding in idiopathic restless legs syndrome with periodic leg movements in sleep","volume":"25","author":"Tribl","year":"2004","journal-title":"Nucl Med Commun"},{"key":"B129","doi-asserted-by":"publisher","first-page":"e1834","DOI":"10.1212\/WNL.0000000000005562","article-title":"Involvement of the central somatosensory system in restless legs syndrome: a neuroimaging study","volume":"90","author":"Lee","year":"2018","journal-title":"Neurology"},{"key":"B130","doi-asserted-by":"publisher","first-page":"e00327","DOI":"10.1002\/brb3.327","article-title":"DTI and VBM reveal white matter changes without associated gray matter changes in patients with idiopathic restless legs syndrome","volume":"5","author":"Belke","year":"2015","journal-title":"Brain Behav"},{"key":"B131","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1111\/j.1468-1331.2011.03604.x","article-title":"Combined brain voxel-based morphometry and diffusion tensor imaging study in idiopathic restless legs syndrome patients","volume":"19","author":"Rizzo","year":"2012","journal-title":"Eur J Neurol"},{"key":"B132","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1002\/ana.410410513","article-title":"Cerebral generators involved in the pathogenesis of the restless legs syndrome","volume":"41","author":"Bucher","year":"1997","journal-title":"Ann Neurol"},{"key":"B133","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1016\/j.neuroimage.2004.10.021","article-title":"Bilateral thalamic gray matter changes in patients with restless legs syndrome","volume":"24","author":"Etgen","year":"2005","journal-title":"Neuroimage"},{"key":"B134","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1002\/1097-4547(20001201)62:5<623::AID-JNR1>3.0.CO;2-H","article-title":"Insight into the pathophysiology of restless legs syndrome","volume":"62","author":"Earley","year":"2015","journal-title":"J Neurosci Res"},{"key":"B135","doi-asserted-by":"publisher","first-page":"378278","DOI":"10.1155\/2011\/378278","article-title":"Dysregulation of iron metabolism in Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis","volume":"2011","author":"Oshiro","year":"2011","journal-title":"Adv Pharmacol Sci"},{"key":"B136","doi-asserted-by":"publisher","first-page":"S440","DOI":"10.1002\/mds.21607","article-title":"The role of iron in restless legs syndrome","volume":"22","author":"Allen","year":"2007","journal-title":"Mov Disord."},{"key":"B137","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1212\/WNL.56.2.263","article-title":"MRI measurement of brain iron in patients with restless legs syndrome","volume":"56","author":"Allen","year":"2001","journal-title":"Neurology"},{"key":"B138","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.sleep.2016.05.001","article-title":"Brain iron deficiency in idiopathic restless legs syndrome measured by quantitative magnetic susceptibility at 7 tesla","volume":"22","author":"Li","year":"2016","journal-title":"Sleep Med"},{"key":"B139","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/00004691-200103000-00004","article-title":"Restless legs syndrome: a review of clinical and pathophysiologic features","volume":"18","author":"Allen","year":"2001","journal-title":"J Clin Neurophysiol"},{"key":"B140","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1212\/01.WNL.0000078887.16593.12","article-title":"Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome","volume":"61","author":"Connor","year":"2003","journal-title":"Neurology"},{"key":"B141","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/mdc3.12025","article-title":"sleep disorders in atypical Parkinsonism","volume":"1","author":"Abbott","year":"2014","journal-title":"Mov Disord Clin Pract"},{"key":"B142","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/j.1365-2990.2007.00907.x","article-title":"Proposed neuropathological criteria for the post mortem diagnosis of multiple system atrophy","volume":"33","author":"Trojanowski","year":"2007","journal-title":"Neuropathol Appl Neurobiol"},{"key":"B143","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1136\/jnnp.72.6.798","article-title":"Sleep disorders and their determinants in multiple system atrophy","volume":"72","author":"Ghorayeb","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B144","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1212\/WNL.48.4.1094","article-title":"REM sleep behavior disorders in multiple system atrophy","volume":"48","author":"Plazzi","year":"1997","journal-title":"Neurology"},{"key":"B145","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1212\/01.WNL.0000073745.68744.94","article-title":"REM sleep behavior disorder is related to striatal monoaminergic deficit in MSA","volume":"61","author":"Gilman","year":"2003","journal-title":"Neurology"},{"key":"B146","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1002\/mds.21668","article-title":"Cerebrospinal fluid hypocretin-1 levels in multiple system atrophy","volume":"22","author":"Martinez-Rodriguez","year":"2007","journal-title":"Mov Disord"},{"key":"B147","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1001\/archneurol.2010.359","article-title":"Excessive daytime sleepiness in multiple system atrophy (SLEEMSA study)","volume":"68","author":"Moreno-Lopez","year":"2011","journal-title":"Arch Neurol"},{"key":"B148","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1093\/brain\/awl357","article-title":"Depletion of putative chemosensitive respiratory neurons in the ventral medullary surface in multiple system atrophy","volume":"130","author":"Benarroch","year":"2007","journal-title":"Brain"},{"key":"B149","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.parkreldis.2007.08.012","article-title":"CSF hypocretin-1 levels are normal in multiple-system atrophy","volume":"14","author":"Abdo","year":"2008","journal-title":"Parkinsonism Relat Disord"},{"key":"B150","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1212\/01.wnl.0000298691.71637.96","article-title":"Mesopontine cholinergic neuron involvement in Lewy body dementia and multiple system atrophy","volume":"70","author":"Schmeichel","year":"2008","journal-title":"Neurology"},{"key":"B151","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/1531-8257(200007)15:4<699::AID-MDS1015>3.0.CO;2-L","article-title":"Stridor and death in multiple system atrophy","volume":"15","author":"Silber","year":"2000","journal-title":"Mov Disord"},{"key":"B152","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.sleep.2003.07.002","article-title":"Sleep disorders in multiple system atrophy: a correlative video-polysomnographic study","volume":"5","author":"Vetrugno","year":"2004","journal-title":"Sleep Med"},{"key":"B153","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1001\/archneur.1960.03840110025004","article-title":"A neurological syndrome associated with orthostatic hypotension: a clinical-pathologic study","volume":"2","author":"Shy","year":"1960","journal-title":"Arch Neurol"},{"key":"B154","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1001\/archneur.64.6.856","article-title":"Daytime hypoxemia, sleep-disordered breathing, and laryngopharyngeal findings in multiple system atrophy","volume":"64","author":"Shimohata","year":"2007","journal-title":"Arch Neurol"},{"key":"B155","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1056\/NEJM198408163110704","article-title":"Involvement of upper-airway muscles in extrapyramidal disorders. A cause of airflow limitation","volume":"311","author":"Vincken","year":"1984","journal-title":"N Engl J Med"},{"key":"B156","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1212\/01.WNL.0000073624.13436.32","article-title":"Obstructive sleep apnea is related to a thalamic cholinergic deficit in MSA","volume":"61","author":"Gilman","year":"2003","journal-title":"Neurology"},{"key":"B157","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.1046\/j.1460-9568.1998.00246.x","article-title":"A population of cholinergic neurons is present in the macaque monkey thalamus","volume":"10","author":"Rico","year":"1998","journal-title":"Eur J Neurosci"},{"key":"B158","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.nbd.2005.03.013","article-title":"Progressive supranuclear palsy: a systematic review","volume":"20","author":"Rampello","year":"2005","journal-title":"Neurobiol Dis"},{"key":"B159","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1001\/archneur.1964.00460160003001","article-title":"Progressive supranuclear palsy. A heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia","volume":"10","author":"Steele","year":"1964","journal-title":"Arch Neurol"},{"key":"B160","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/sleep\/28.3.349","article-title":"REM sleep behavior disorder and REM sleep without atonia in patients with progressive supranuclear palsy","volume":"28","author":"Arnulf","year":"2005","journal-title":"Sleep"},{"key":"B161","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1002\/gps.1945","article-title":"Visual hallucinations and symptoms of REM sleep behavior disorder in Parkinsonian tauopathies","volume":"23","author":"Diederich","year":"2008","journal-title":"Int J Geriatr Psychiatry"},{"key":"B162","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.sleep.2008.05.004","article-title":"Polysomnographic findings, video-based sleep analysis and sleep perception in progressive supranuclear palsy","volume":"10","author":"Sixel-Doring","year":"2009","journal-title":"Sleep Med"},{"key":"B163","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1097\/WCO.0b013e32833be924","article-title":"Neuropathology of variants of progressive supranuclear palsy","volume":"23","author":"Dickson","year":"2010","journal-title":"Curr Opin Neurol"},{"key":"B164","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1093\/brain\/awh391","article-title":"Cholinergic systems in progressive supranuclear palsy","volume":"128","author":"Warren","year":"2005","journal-title":"Brain"},{"key":"B165","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1212\/01.WNL.0000165960.04422.D0","article-title":"New and reliable MRI diagnosis for progressive supranuclear palsy","volume":"64","author":"Oba","year":"2005","journal-title":"Neurology"},{"key":"B166","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/mds.23293","article-title":"MRI measurements of brainstem structures in patients with Richardson's syndrome, progressive supranuclear Palsy-Parkinsonism, and Parkinson's disease","volume":"26","author":"Longoni","year":"2011","journal-title":"Mov Disord"},{"key":"B167","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1212\/WNL.0b013e318292a2d2","article-title":"The midbrain to pons ratio: a simple and specific MRI sign of progressive supranuclear palsy","volume":"80","author":"Massey","year":"2013","journal-title":"Neurology"},{"key":"B168","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1111\/j.1468-1331.2012.03884.x","article-title":"Subcortical structures in progressive supranuclear palsy: vertex-based analysis","volume":"20","author":"Saini","year":"2013","journal-title":"Eur J Neurol"},{"key":"B169","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1111\/ene.12004","article-title":"Neuroimaging comparison of primary progressive apraxia of speech and progressive supranuclear palsy","volume":"20","author":"Whitwell","year":"2013","journal-title":"Eur J Neurol"},{"key":"B170","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1136\/jnnp.2005.075713","article-title":"Diffusion tensor imaging and voxel based morphometry study in early progressive supranuclear palsy","volume":"77","author":"Padovani","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B171","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1093\/brain\/awh508","article-title":"Clinical deficits correlate with regional cerebral atrophy in progressive supranuclear palsy","volume":"128","author":"Cordato","year":"2005","journal-title":"Brain"},{"key":"B172","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.neuroimage.2004.06.013","article-title":"Voxel-based morphometry detects patterns of atrophy that help differentiate progressive supranuclear palsy and Parkinson's disease","volume":"23","author":"Price","year":"2004","journal-title":"Neuroimage"},{"key":"B173","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1002\/mds.23739","article-title":"Diffusion tensor magnetic resonance imaging tractography in progressive supranuclear palsy","volume":"26","author":"Canu","year":"2011","journal-title":"Mov Disord."},{"key":"B174","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s00234-011-0983-7","article-title":"In vivo evaluation of white matter pathology in patients of progressive supranuclear palsy using TBSS","volume":"54","author":"Saini","year":"2012","journal-title":"Neuroradiology"},{"key":"B175","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.parkreldis.2014.01.023","article-title":"Diffusion tensor imaging comparison of progressive supranuclear palsy and corticobasal syndromes","volume":"20","author":"Whitwell","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"key":"B176","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.1093\/brain\/awq162","article-title":"Magnetic resonance imaging lesion pattern in Guadeloupean Parkinsonism is distinct from progressive supranuclear palsy","volume":"133","author":"Lehericy","year":"2010","journal-title":"Brain"},{"key":"B177","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s00424-011-1014-6","article-title":"The sleep relay\u2013the role of the thalamus in central and decentral sleep regulation","volume":"463","author":"Coulon","year":"2012","journal-title":"Pflugers Arch"},{"key":"B178","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1053\/smrv.2000.0136","article-title":"Brain structures and mechanisms involved in the generation of REM sleep","volume":"5","author":"Reinoso-Suarez","year":"2001","journal-title":"Sleep Med Rev"},{"key":"B179","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1212\/WNL.0b013e3182886a76","article-title":"Pedunculopontine nucleus: functional organization and clinical implications","volume":"80","author":"Benarroch","year":"2013","journal-title":"Neurology"},{"key":"B180","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1093\/brain\/112.5.1171","article-title":"Corticobasal degeneration","volume":"112","author":"Gibb","year":"1989","journal-title":"Brain"},{"key":"B181","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1093\/sleep\/20.10.891","article-title":"Subclinical REM sleep behavior disorder in a patient with corticobasal degeneration","volume":"20","author":"Kimura","year":"1997","journal-title":"Sleep"},{"key":"B182","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S1389-9457(01)00097-1","article-title":"Sleep and periodic limb movements in corticobasal degeneration","volume":"3","author":"Wetter","year":"2002","journal-title":"Sleep Med"},{"key":"B183","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.parkreldis.2008.01.011","article-title":"Photophobia, visual hallucinations, and REM sleep behavior disorder in progressive supranuclear palsy and corticobasal degeneration: a prospective study","volume":"15","author":"Cooper","year":"2009","journal-title":"Parkinsonism Relat Disord"},{"key":"B184","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.neucli.2007.05.002","article-title":"Sleep and vigilance in corticobasal degeneration: a descriptive study","volume":"37","author":"Roche","year":"2007","journal-title":"Neurophysiol Clin"},{"key":"B185","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jns.2006.08.004","article-title":"CSF orexin levels of Parkinson's disease, dementia with Lewy bodies, progressive supranuclear palsy and corticobasal degeneration","volume":"250","author":"Yasui","year":"2006","journal-title":"J Neurol Sci"},{"key":"B186","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s00401-002-0621-x","article-title":"Cholinergic neuronal loss in the basal forebrain and mesopontine tegmentum of progressive supranuclear palsy and corticobasal degeneration","volume":"105","author":"Kasashima","year":"2003","journal-title":"Acta Neuropathol"},{"key":"B187","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41531-017-0012-6","article-title":"Disentangling the neural correlates of corticobasal syndrome and corticobasal degeneration with systematic and quantitative ALE meta-analyses","volume":"3","author":"Albrecht","year":"2017","journal-title":"NPJ Parkinsons Dis"},{"key":"B188","doi-asserted-by":"publisher","first-page":"e18301","DOI":"10.1371\/journal.pone.0018301","article-title":"Dopamine transporter SPECT imaging in corticobasal syndrome","volume":"6","author":"Cilia","year":"2011","journal-title":"PLoS ONE"},{"key":"B189","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1093\/jnen\/60.4.393","article-title":"Substantia nigra in progressive supranuclear palsy, corticobasal degeneration, and Parkinsonism-dementia complex of Guam: specific pathological features","volume":"60","author":"Oyanagi","year":"2001","journal-title":"J Neuropathol Exp Neurol"},{"key":"B190","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1093\/jnen\/61.11.935","article-title":"Office of Rare Diseases neuropathologic criteria for corticobasal degeneration","volume":"61","author":"Dickson","year":"2002","journal-title":"J Neuropathol Exp Neurol"},{"key":"B191","doi-asserted-by":"publisher","first-page":"3016","DOI":"10.1093\/brain\/awv214","article-title":"Altered PDE10A expression detectable early before symptomatic onset in Huntington's disease","volume":"138","author":"Niccolini","year":"2015","journal-title":"Brain"},{"key":"B192","first-page":"971","article-title":"The Huntington's Disease Collaborative Research Group","volume":"72","year":"1993","journal-title":"Cell"},{"key":"B193","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S0092-8674(00)80513-9","article-title":"Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation","volume":"90","author":"Davies","year":"1997","journal-title":"Cell"},{"key":"B194","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1128\/MCB.22.5.1277-1287.2002","article-title":"Interaction of Huntington disease protein with transcriptional activator Sp1","volume":"22","author":"Li","year":"2002","journal-title":"Mol Cell Biol"},{"key":"B195","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/j.1755-5949.2010.00134.x","article-title":"Dopamine and glutamate in Huntington's disease: a balancing act","volume":"16","author":"Andre","year":"2010","journal-title":"CNS Neurosci Ther"},{"key":"B196","doi-asserted-by":"publisher","first-page":"301","DOI":"10.4329\/wjr.v6.i6.301","article-title":"Neuroimaging in Huntington's disease","volume":"6","author":"Niccolini","year":"2014","journal-title":"World J Radiol"},{"key":"B197","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1212\/WNL.35.11.1672","article-title":"Sleep disturbances and severity of Huntington's disease","volume":"35","author":"Hansotia","year":"1985","journal-title":"Neurology"},{"key":"B198","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1001\/archneur.65.4.482","article-title":"Rapid eye movement sleep disturbances in Huntington disease","volume":"65","author":"Arnulf","year":"2008","journal-title":"Arch Neurol"},{"key":"B199","doi-asserted-by":"publisher","first-page":"2860","DOI":"10.1093\/brain\/awn244","article-title":"Hypothalamic involvement in Huntington's disease: an In vivo PET study","volume":"131","author":"Politis","year":"2008","journal-title":"Brain"},{"key":"B200","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/hbm.21008","article-title":"Microglial activation in regions related to cognitive function predicts disease onset in Huntington's disease: a multimodal imaging study","volume":"32","author":"Politis","year":"2011","journal-title":"Hum Brain Mapp"},{"key":"B201","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S0074-7696(04)40003-5","article-title":"Neuropeptides in hypothalamic neuronal disorders","volume":"240","author":"Swaab","year":"2004","journal-title":"Int Rev Cytol"},{"key":"B202","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1111\/j.1460-9568.2006.04985.x","article-title":"Hypothalamic-endocrine aspects in Huntington's disease","volume":"24","author":"Petersen","year":"2006","journal-title":"Eur J Neurosci"},{"key":"B203","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3233\/JHD-2012-120006","article-title":"Hypothalamic and limbic system changes in Huntington's Disease","volume":"1","author":"Petersen","year":"2012","journal-title":"J Huntingtons Dis"},{"key":"B204","first-page":"213","article-title":"Topography of cerebral atrophy in early Huntington's disease: a voxel based morphometric MRI study","volume":"75","author":"Kassubek","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B205","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1016\/j.neuroimage.2006.05.057","article-title":"Distribution of grey matter atrophy in Huntington's disease patients: a combined ROI-based and voxel-based morphometric study","volume":"32","author":"Douaud","year":"2006","journal-title":"Neuroimage"},{"key":"B206","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.nbd.2010.07.013","article-title":"Early changes in the hypothalamic region in prodromal Huntington disease revealed by MRI analysis","volume":"40","author":"Soneson","year":"2010","journal-title":"Neurobiol Dis"},{"key":"B207","doi-asserted-by":"publisher","first-page":"S387","DOI":"10.1016\/S1353-8020(08)70035-X","article-title":"Hypocretin-1 and secondary signs in Huntington's disease","volume":"13","author":"Roos","year":"2007","journal-title":"Parkinsonism Relat Disord."},{"key":"B208","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1093\/brain\/awg067","article-title":"Inhibition of subliminally primed responses is mediated by the caudate and thalamus: evidence from functional MRI and Huntington's disease","volume":"126","author":"Aron","year":"2003","journal-title":"Brain"},{"key":"B209","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1093\/cercor\/bhh185","article-title":"Thalamic atrophy in Huntington's disease co-varies with cognitive performance: a morphometric MRI analysis","volume":"15","author":"Kassubek","year":"2005","journal-title":"Cereb Cortex"},{"key":"B210","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1136\/jnnp.2009.190702","article-title":"The progression of regional atrophy in premanifest and early Huntington's disease: a longitudinal voxel-based morphometry study","volume":"81","author":"Hobbs","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2018.00767\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T10:34:11Z","timestamp":1537871651000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2018.00767\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,11]]},"references-count":210,"alternative-id":["10.3389\/fneur.2018.00767"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2018.00767","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,11]]},"article-number":"767"}}